A Case of Successful FTD/TPI for Postoperative Recurrence of Signet-ring Cell Carcinoma of the Ascending Colon

Chie Hagiwara, A. Tsutsui, R. Nakanishi, H. Osada, M. Sugitani, T. Naito
{"title":"A Case of Successful FTD/TPI for Postoperative Recurrence of Signet-ring Cell Carcinoma of the Ascending Colon","authors":"Chie Hagiwara, A. Tsutsui, R. Nakanishi, H. Osada, M. Sugitani, T. Naito","doi":"10.3862/jcoloproctology.75.409","DOIUrl":null,"url":null,"abstract":"The patient was an 80-year-old man. He visited our hospital because elevated tumor marker levels were noted during a physical examination. Lower gastrointestinal endoscopy showed a type 0- Ⅱ a lesion in the ascending colon, and a biopsy indicated the presence of adenocarcinoma (por/sig). A computed tomography scan showed many enlarged lymph nodes in the ileocecum. Therefore, he was diagnosed as having a cT1bN2bM0-stage ascending colon carcinoma. On performing lap-aroscopic ileocecal resection, a 20-mm-large mass was detected in the subserosa of the resected tissue. It was identified as a lymph node that had enlarged due to metastasis of the mucinous carcinoma. On performing additional resection, a signet-ring cell carcinoma lesion was detected in the ascending colon near the metastatic site. Therefore, the patient was diagnosed as having a pT3 (Ly) N2bM0-stage ascending colon carcinoma. After adjuvant chemotherapy with CAPOX, paratra-cheal lymph node metastasis and peritoneal dissemination recurrence were confirmed. However, after switching to FTD/ TPI, the peritoneal dissemination reduced and tumor marker levels normalized. Although signet-ring cell carcinoma of the colon is rare and often difficult to treat, we experienced a patient who was successfully treated after recurrence. Thus, we report this case, with a review of the literature.","PeriodicalId":78496,"journal":{"name":"Nihon Daicho Komonbyo Gakkai zasshi","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nihon Daicho Komonbyo Gakkai zasshi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3862/jcoloproctology.75.409","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The patient was an 80-year-old man. He visited our hospital because elevated tumor marker levels were noted during a physical examination. Lower gastrointestinal endoscopy showed a type 0- Ⅱ a lesion in the ascending colon, and a biopsy indicated the presence of adenocarcinoma (por/sig). A computed tomography scan showed many enlarged lymph nodes in the ileocecum. Therefore, he was diagnosed as having a cT1bN2bM0-stage ascending colon carcinoma. On performing lap-aroscopic ileocecal resection, a 20-mm-large mass was detected in the subserosa of the resected tissue. It was identified as a lymph node that had enlarged due to metastasis of the mucinous carcinoma. On performing additional resection, a signet-ring cell carcinoma lesion was detected in the ascending colon near the metastatic site. Therefore, the patient was diagnosed as having a pT3 (Ly) N2bM0-stage ascending colon carcinoma. After adjuvant chemotherapy with CAPOX, paratra-cheal lymph node metastasis and peritoneal dissemination recurrence were confirmed. However, after switching to FTD/ TPI, the peritoneal dissemination reduced and tumor marker levels normalized. Although signet-ring cell carcinoma of the colon is rare and often difficult to treat, we experienced a patient who was successfully treated after recurrence. Thus, we report this case, with a review of the literature.
FTD/TPI成功治疗升结肠印戒细胞癌术后复发1例
患者是一名80岁的男性。他来我们医院是因为在体检中发现肿瘤标志物水平升高。下消化道内窥镜检查显示0-Ⅱ型升结肠病变,活检提示腺癌(por/sig)的存在。计算机断层扫描显示回盲部有许多肿大的淋巴结。因此,他被诊断为ct1bn2bm0期升结肠癌。在腹腔镜下进行回盲切除术时,在切除组织的浆膜下发现了一个20mm大的肿块。它被确定为一个淋巴结肿大,由于转移的粘液癌。在进行额外的切除时,在转移部位附近的升结肠中检测到印戒细胞癌病变。因此,患者被诊断为pT3 (Ly) n2bm0期升结肠癌。经CAPOX辅助化疗后,证实气管旁淋巴结转移及腹膜播散复发。然而,改用FTD/ TPI后,腹膜播散减少,肿瘤标志物水平恢复正常。虽然结肠印戒细胞癌是罕见的,往往难以治疗,我们经历了一个病人成功地治疗后复发。因此,我们报告了这个病例,并回顾了文献。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信